PsyPost on MSN2h
Breakthrough study shows how ketamine may ease dyskinesia in Parkinson’s patients
A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...
The Tab3h
Jeni Larmour’s mum calls for reclassification of Ketamine to class A following her death
Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, Jeni’s mum, is now calling for the reclassification of the drug, claiming ...
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
IFLScience4h
FDA Approves First-Ever Standalone Therapy For Treatment-Resistant Depression
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
EMS14h
Insider Analysis: ‘We keep making the same mistakes’
A fatal medication error and subsequent involuntary manslaughter charge highlights the ongoing challenges of error reporting in EMS ...
Burnley Express10h
Pendle man who battled ketamine addiction warns people about the drug
A Colne man who lost his football scholarship in America due to a ketamine addiction is warning people about the dangers of ...
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...